Perioperative/Postoperative Complications Clinical Trial
— TEAMS2Official title:
Clinical Characteristics and Functional Outcomes of Postoperative Myocardial Injury: A Prospective Cohort Study - Troponin Elevation After Major Noncardiac Surgery 2
NCT number | NCT03408522 |
Other study ID # | TEAMS2 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 29, 2018 |
Est. completion date | December 31, 2019 |
Major adverse cardiac events (MACE) are a leading cause of mortality in patients undergoing noncardiac surgery. Patients with perioperative myocardial injury (PMI), defined as either myocardial infarction and lower elevations in cardiac troponin, are also at substantially increased risk of additional cardiac and noncardiac complications. Accordingly, it is plausible to assume that PMI negatively affects quality of life in terms of disability. The aim of this study is to investigate and compare the independent prognostic effects of the different PMI phenotypes (myocardial infarction and non-infarct troponin elevations) and noncardiac complications on disability in patients undergoing elective noncardiac surgery.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | December 31, 2019 |
Est. primary completion date | June 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - = 60 years old; - Major noncardiac surgery defined as all noncardiac surgical procedures requiring an expected hospital stay of at least 24 hours; - Elective surgery, defined as surgery that that has been preceded by a preoperative consultation at the anesthesia preoperative screening outpatient clinic. Exclusion Criteria: - Patients unable to fully comply to study needs (e.g. legally incapable patients or patients unable to communicate in Dutch or English). - Patients with an American Society of Anesthesiologists (ASA) Physical status 5 |
Country | Name | City | State |
---|---|---|---|
Canada | Toronto General Hospital | Toronto | Ontario |
Canada | Toronto Western Hospital | Toronto | Ontario |
Netherlands | UMC Utrecht | Utrecht |
Lead Sponsor | Collaborator |
---|---|
UMC Utrecht | University Health Network, Toronto |
Canada, Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disability | Disability is expressed by the World Health Organization Disability Assessment Score 2.0 (WHODAS 2.0), which is based on difficulties experienced by the respondent in different functional domains including, cognition, mobility, self-care, getting along, life activities and participation during the previous 30 days. Disability is defined as a decrement in each functioning domain corresponding to score between 0% and 100%, in which no disability stands for a score of 0% and full disability represents a score of 100%, including death. | 6 months after surgery | |
Secondary | Disability free survival | Disability free survival is defined as being alive with a WHODAS 2.0 score = 25% and no increase of the pre-operative score = 25% at 6 months after surgery. | 6 months after surgery | |
Secondary | Major adverse cardiovascular event (MACE) | MACE is defined as a composite outcome consisting of cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, non-fatal ventricular fibrillation, ventricular arrhythmia with hemodynamic compromise, atrial fibrillation requiring cardioversion, pulmonary embolism, stroke | 1 week after surgery | |
Secondary | Noncardiac major adverse postoperative events (MAPE) | Noncardiac MAPE is a composite outcome consisting of respiratory failure (including pneumonia and hypoxia or hypercapnia leading to ICU admission for respiratory support), sepsis, renal failure, unplanned ICU admission, unplanned medium care admission, reoperation | 1 week after surgery | |
Secondary | Length of hospital stay | the number of days from the end of surgery until day of discharge | 1 week after surgery | |
Secondary | All-cause mortality | 1 week after surgery | ||
Secondary | Major adverse cardiovascular event (MACE) | 6 months after surgery | ||
Secondary | All-cause mortality | 6 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Active, not recruiting |
NCT01681238 -
Goal-directed Therapy in High-risk Surgery
|
N/A | |
Recruiting |
NCT05613439 -
The Fast-track Centre for Hip and Knee Replacement Database
|
||
Recruiting |
NCT03740438 -
Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
|
||
Completed |
NCT03269760 -
Multimodal Sleep Pathway for Shoulder Arthroplasty
|
Phase 1 | |
Recruiting |
NCT05594199 -
Feasibility of a Virtual Smoking Cessation Program
|
N/A | |
Completed |
NCT00538499 -
Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery
|
N/A | |
Recruiting |
NCT01690338 -
A Study of Residual Curarization Incidence in China
|
Phase 4 | |
Recruiting |
NCT01110798 -
J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the Tumor
|
N/A | |
Completed |
NCT00859157 -
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
|
N/A | |
Withdrawn |
NCT03531268 -
Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing
|
N/A | |
Recruiting |
NCT04356638 -
a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients
|
Phase 3 | |
Completed |
NCT03579121 -
Genomic Opioid Optimization of Dosing and Selections (GOODS) Study
|
N/A | |
Completed |
NCT03899441 -
Multimedia Aid Gynecologic Counseling and Consent
|
N/A | |
Recruiting |
NCT06123039 -
Use of Heart-lung Interaction to Predict Haemodynamic Tolerance to the Open Lung Approach With Individualised PEEP
|
||
Completed |
NCT01672892 -
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
|
Phase 3 | |
Completed |
NCT01510652 -
More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
|
N/A | |
Completed |
NCT01680367 -
Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery
|
N/A | |
Active, not recruiting |
NCT00005600 -
Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer
|
N/A | |
Recruiting |
NCT05743673 -
SHAPE Test for Preoperative Risk Stratification
|